0001193125-13-249750.txt : 20130606 0001193125-13-249750.hdr.sgml : 20130606 20130606140736 ACCESSION NUMBER: 0001193125-13-249750 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130531 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20130606 DATE AS OF CHANGE: 20130606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CACI INTERNATIONAL INC /DE/ CENTRAL INDEX KEY: 0000016058 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 541345888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31400 FILM NUMBER: 13896937 BUSINESS ADDRESS: STREET 1: 1100 N GLEBE ST CITY: ARLINGTON STATE: VA ZIP: 22201 BUSINESS PHONE: 7038417800 MAIL ADDRESS: STREET 1: 1100 NORTH GLEBE ROAD CITY: ARLINGTON STATE: VA ZIP: 22201 FORMER COMPANY: FORMER CONFORMED NAME: CACI INC /DE/ DATE OF NAME CHANGE: 19870119 FORMER COMPANY: FORMER CONFORMED NAME: CONSOLIDATED ANALYSIS CENTERS INC DATE OF NAME CHANGE: 19730102 FORMER COMPANY: FORMER CONFORMED NAME: CALIFORNIA ANALYSIS CENTER INC DATE OF NAME CHANGE: 19680603 8-K 1 d548610d8k.htm FORM 8-K FORM 8-K

 

 

 

U. S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

May 31, 2013

(Date of Report–Date of Earliest Event Reported)

 

 

CACI International Inc

(Exact name of registrant as specified in its Charter)

 

 

 

Delaware   001-31400   54-1345899

(State or other jurisdiction

of incorporation)

  (Commission file number)  

(IRS Employer

Identification No.)

1100 N. Glebe Road,

Arlington, Virginia 22201

(Address of Principal executive offices) (ZIP code)

(703) 841-7800

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.142-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


ITEM 5.02(d) DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS, APPOINTMENT OF PRINCIPAL OFFICERS.

 

(1) Mr. William L. Jews was appointed to our Board of Directors effective May 31, 2013.

 

(2) There is no arrangement or understanding between Mr. Jews and any other person pursuant to which he was selected as a director.

 

(3) At this time, it is expected that Mr. Jews will be appointed to the Audit, Investor Relations, and Strategic Assessment Committees of our Board of Directors.

 

(4) There are no transactions of the kind described in Item 404(a) of Regulation S-K in which Mr. Jews was a participant.

 

(5) There is no plan, contract or arrangement that was entered into or materially modified in connection with Mr. Jews’ appointment.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(d)

  

Exhibit

Exhibit 99    Copy of the Registrant’s press release dated June 6, 2013 is attached as Exhibit 99 to this current report on Form 8-K.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

CACI International Inc
By:   /s/ Arnold D. Morse
 

Arnold D. Morse

Senior Vice President,

Chief Legal Officer and Secretary

Dated: June 6, 2013

EX-99.1 2 d548610dex991.htm EXHIBIT 99.1 EXHIBIT 99.1

Exhibit 99.1

CACI Appoints William L. Jews to Board of Directors

Industry Leader Brings Extensive Experience in Healthcare and Organizational Growth

Arlington, Va., June 6, 2013 – CACI International Inc (NYSE:CACI) announced today that it has appointed William L. Jews to CACI’s Board of Directors. Mr. Jews is a senior business and healthcare executive with over 25 years’ experience leading organizational growth, completing successful mergers and acquisitions, achieving profit goals, and delivering superior customer service.

Mr. Jews has served as President and CEO of major healthcare organizations, most recently at CareFirst, the nation’s seventh largest Blue Cross Blue Shield Plan. He has also held leadership roles with business, professional, civic, governmental and educational organizations. Mr. Jews currently serves on the boards of several public corporations.

CACI Executive Chairman and Chairman of the Board Dr. J.P. (Jack) London said, “The selection of William L. Jews continues CACI’s history of appointing strongly credentialed and highly qualified industry leaders to our Board. Mr. Jews brings outstanding experience as a business executive with an exceptional track record of organizational growth and customer satisfaction, along with significant expertise in board governance and public service. We welcome him to CACI and look forward to his contributions in helping to lead our company and sustain our commitment to delivering shareholder value.”

CACI provides information solutions and services in support of national security missions and government transformation for Intelligence, Defense, and Federal Civilian clients. A member of the Fortune 1000 Largest Companies and the Russell 2000 Index, CACI provides dynamic careers for approximately 15,000 employees working in over 120 offices worldwide. Visit www.caci.com.

There are statements made herein which do not address historical facts, and therefore could be interpreted to be forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to factors that could cause actual results to differ materially from anticipated results. The factors that could cause actual results to differ materially from those anticipated include, but are not limited to, the risk factors set forth in CACI’s Annual Report on Form 10-K for the fiscal year ended June 30, 2012, and other such filings that CACI makes with the Securities and Exchange Commission from time to time. Any forward-looking statements should not be unduly relied upon and only speak as of the date hereof.

# # #

 

Corporate Communications and Media:   Investor Relations:
Jody Brown, Executive Vice President, Public Relations   David Dragics, Senior Vice President, Investor Relations
(703) 841-7801, jbrown@caci.com   (866) 606-3471, ddragics@caci.com

CACI-HR